IMAX CORP — Institutional Ownership
Which tracked institutions hold IMAX, and how they changed the position last quarter. Latest holdings as of Mar 31, 2026. Source: SEC 13-F filings.
24
Funds holding
$356106201
Total value held
Buying
12 added/new · 11 reduced
| # | Institution | Value | Shares | Δ Shares | Change (QoQ) |
|---|---|---|---|---|---|
| 1 | Blackrock, Inc. | $99684646 | 2622590 | -26090 | -0.99% |
| 2 | Ameriprise Financial Inc | $50499964 | 1328595 | +250629 | +23.25% |
| 3 | Barclays Plc | $34637828 | 911282 | — | NEW BUY |
| 4 | State Street Corp | $34151795 | 898495 | -3771 | -0.42% |
| 5 | Goldman Sachs Group Inc | $33034952 | 869112 | +326498 | +60.17% |
| 6 | Bank Of America Corp /De/ | $16120241 | 424105 | -67594 | -13.75% |
| 7 | Wells Fargo & Company/Mn | $13128156 | 355199 | -549039 | -60.72% |
| 8 | Northern Trust Corp | $11462258 | 301559 | +8527 | +2.91% |
| 9 | Janus Henderson Group Plc | $9923587 | 261059 | — | NEW BUY |
| 10 | Nomura Holdings Inc | $9246579 | 243267 | — | NEW BUY |
| 11 | Bank Of New York Mellon Corp | $7691145 | 202345 | -9668 | -4.56% |
| 12 | Morgan Stanley | $7580620 | 199437 | -131408 | -39.72% |
| 13 | Principal Financial Group Inc | $7302481 | 192120 | +83118 | +76.25% |
| 14 | Raymond James Financial Inc | $7098357 | 188848 | -6291 | -3.22% |
| 15 | Sei Investments Co | $7033440 | 185045 | — | NEW BUY |
| 16 | Royal Bank Of Canada | $2880000 | 75777 | — | NEW BUY |
| 17 | Franklin Resources Inc | $1479805 | 38932 | -8849 | -18.52% |
| 18 | Invesco Ltd. | $1075499 | 29099 | -10001 | -25.58% |
| 19 | Citigroup Inc | $804323 | 21762 | -45007 | -67.41% |
| 20 | Pnc Financial Services Group, Inc. | $522789 | 13754 | -388 | -2.74% |
| 21 | Us Bancorp \De\ | $480789 | 12649 | +510 | +4.20% |
| 22 | Prudential Financial Inc | $266450 | 7010 | — | NEW BUY |
| 23 | Fifth Third Bancorp | $380 | 10 | — | Held |
| 24 | Amalgamated Financial Corp. | $117 | 6207 | — | NEW BUY |
Aggregated across tracked institutional filers. Reported quarterly on SEC Form 13-F and may lag. For research only — not investment advice.